| Collection of Detailed Ethnicity to Enable Ethnicity-Specific Analyses of PLCO Data |
Lance Yokochi |
PHREI |
PLCO |
Jul 1, 2006 |
2006-0268 |
| Using the SF-36 to Track Health Status Outcomes Among Participants in the PLCO |
Lance Yokochi |
PHREI |
PLCO |
Jul 1, 2006 |
2006-0270 |
| Colorectal Adenoma -Dietary Factors Carotenoids |
Regina Ziegler |
NCI, DCEG, EBP |
PLCO |
Jul 1, 2006 |
2006-0273 |
| Colorectal Adenoma -One-Carbon Metabolism, Biochemical and Genetic |
Regina Ziegler |
NCI, DCEG, EBP |
PLCO |
Jul 1, 2006 |
2006-0275 |
| Colorectal Adenoma and Tocopherols, Carotenoids |
Regina Ziegler |
NCI, DCEG, EBP |
PLCO |
Jul 1, 2006 |
2006-0276 |
| Racial Factors and Compliance with PLCO Procedures |
Joel Weissfeld |
University of Pittsburgh |
PLCO |
Jul 1, 2006 |
2006-0278 |
| HSQ Validation Study |
Lisa Gren |
University of Utah |
PLCO |
Jul 1, 2006 |
2006-0310 |
| Effects of Distance and Screening Type on Compliance |
Sheryl Ogden |
University of Colorado Health Sciences Center |
PLCO |
Jul 1, 2006 |
2006-0311 |
| Recruitment of Minorities in the PLCO Trial |
Paul Pinsky |
NCI, DCP, EDRG |
PLCO |
Jul 1, 2006 |
2006-0312 |
| Diagnostic Procedures Following Lung Cancer Screens with non-Cancer Abnormalities |
Lois Lamerato |
Henry Ford Health System |
PLCO |
Jul 1, 2006 |
2006-0315 |
| Questionnaire Risk Factors and Multiple Disease Outcomes in PLCO |
Wen-Yi Huang |
NCI, DCEG, OEEB |
PLCO |
Jul 1, 2006 |
2006-0321 |
| Serum Protein Markers of Early Oncogenic Events: A Pre-Diagnostic Study of Multiple Myeloma |
Ola Landgren |
NCI, DCEG, GEB |
PLCO |
Jun 7, 2006 |
2005-0017 |
| Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer |
Anil Chaturvedi |
NCI, DCEG, IIB |
PLCO |
Apr 21, 2006 |
2005-0014 |
| Serum Levels of Cytokines, Other Immunologic Markers and non-Hodgkin Lymphoma: A Nested Case-Control Study in the PLCO Trial |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Apr 21, 2006 |
2005-0015 |
| Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk |
Demetrius Albanes |
Extramural |
PLCO |
Apr 21, 2006 |
2005-0018 |
| Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial |
Mark Purdue |
NCI, DCEG, OEEB |
PLCO |
Apr 21, 2006 |
2005-0021 |
| Insulin Resistance-Related Metabolic Markers and Pancreatic Cancer Risk |
Rachael Stolzenberg-Solomon |
NCI, DCEG, NEB |
PLCO |
Apr 21, 2006 |
2005-0024 |
| Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers |
Unhee Lim |
NCI, DCEG, NEB |
PLCO |
Apr 21, 2006 |
2005-0025 |
| Alcohol intake, genes responsible for alcohol metabolism, and risk of breast cancer in the PLCO cohort |
Catherine McCarty |
Marshfield Clinic Research Foundation |
PLCO |
Apr 21, 2006 |
2005-0027 |
| Measuring carcinogen metabolite levels in long-term smokers and estimating the risk of lung cancer |
Timothy Church |
University of Minnesota |
PLCO |
Apr 21, 2006 |
2005-0029 |
